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A single-nucleotide polymorphism in the human arylamine N-ace-
tyltransferase 2 (Nat2) gene has recently been identified as asso-
ciated with insulin resistance in humans. To understand the
cellular and molecular mechanisms by which alterations in
Nat2 activity might cause insulin resistance, we examined murine
ortholog Nat1 knockout (KO) mice. Nat1 KO mice manifested
whole-body insulin resistance, which could be attributed to re-
duced muscle, liver, and adipose tissue insulin sensitivity. Hepatic
and muscle insulin resistance were associated with marked in-
creases in both liver and muscle triglyceride (TAG) and diacylgly-
cerol (DAG) content, which was associated with increased PKCe
activation in liver and increased PKCθ activation in skeletal muscle.
Nat1 KO mice also displayed reduced whole-body energy expen-
diture and reduced mitochondrial oxygen consumption in white
adipose tissue, brown adipose tissue, and hepatocytes. Taken to-
gether, these studies demonstrate that Nat1 deletion promotes
reduced mitochondrial activity and is associated with ectopic
lipid-induced insulin resistance. These results provide a potential
genetic link among mitochondrial dysfunction with increased ec-
topic lipid deposition, insulin resistance, and type 2 diabetes.
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Insulin resistance in liver and skeletal muscle is a major factor inthe pathogenesis of type 2 diabetes; however, the molecular
mechanism or mechanisms responsible for this phenomenon
have not been established. In this context, several cellular
mechanisms have been proposed to be responsible for insulin
resistance in these tissues, including alterations in circulating
adipocytokines resulting from inflammation (1, 2), increased
endoplasmic reticulum stress (3, 4), and increases in ectopic lipid
[diacylglycerol (DAG) (5–9) and ceramide (10–12)] content.
Recently, a genome-wide association study found an associa-
tion with a single-nucleotide polymorphism in the human
N-acetyltransferase 2 (Nat2) gene associated with insulin re-
sistance in humans (13). This study also found that knockdown of
Nat1 caused insulin resistance in murine 3T3-L1 adipocytes and
that Nat1 (the murine ortholog of Nat2) knockout (KO) mice
displayed decreased glucose tolerance, suggesting whole-body
insulin resistance (13). Nevertheless, the mechanisms by which al-
terations in the Nat1 gene might cause insulin resistance is un-
known. To address this question, we performed comprehensive
metabolic analyses of regular chow (RC)-fed and high-fat diet
(HFD)-fed Nat1 KO mice. Specifically, we examined basal and
insulin-stimulated rates of liver, muscle, and white adipose tissue
(WAT) glucose metabolism assessed during a hyperinsulinemic-
euglycemic clamp combined with [3-3H]glucose, [2H5]glycerol,
and [13C16]palmitate infusions. These measurements were
combined with assessment of whole-body energy expenditure,
activity, food intake, and 1H NMR assessment of lean body
and fat mass along with liquid chromatography-tandem mass
spectrometry (LC-MS/MS) analyses of liver and muscle lipid
intermediates (DAGs, ceramides) that have been implicated in
causing insulin resistance in liver and skeletal muscle.
Results
Nat1 Deficiency Causes Whole-Body Insulin Resistance. The WT and
Nat1 KO mice were studied at 12 wk of age and displayed no
differences in body weight or body fat between groups when fed
either RC or a HFD for 4 wk (Table 1).
To evaluate whether the Nat1 deficiency would cause insulin
resistance and, if so, to determine which tissues were responsible for
the insulin resistance, we performed hyperinsulinemic-euglycemic
clamp studies combined with radiolabeled glucose in Nat1 KO
and WT littermate mice. The deficiency of Nat1 in RC-fed mice
caused whole-body insulin resistance, reflected by a marked re-
duction in the glucose infusion rate required to maintain eugly-
cemia during the hyperinsulinemic-euglycemic clamp (Fig. 1A).
This difference in glucose infusion rate was partially accounted for
by reduction in peripheral insulin sensitivity in the Nat1 KO mice.
The Nat1 KO mice displayed reduced insulin-stimulated muscle
and WAT glucose uptake, as well as reduced insulin-stimulated
whole-body glucose turnover (Fig. 1 B and C). Nat1 KO mice
also manifested hepatic insulin resistance, as reflected by re-
duced insulin-stimulated suppression of endogenous glucose
production during the clamp (Fig. 1D). Although it has been
shown that Nat1 deficiency in vitro induced increased lipolysis
Significance
Insulin resistance in liver and skeletal muscle are major factors
in the pathogenesis of type 2 diabetes; however, the molecular
mechanism or mechanisms responsible for this phenomenon
have not been established. Recently, an association of a single-
nucleotide polymorphism in the human N-acetyltransferase 2
(Nat2) gene with insulin resistance in humans was found. Here,
we show that the murine ortholog Nat1 knockout (KO) mice
manifested whole-body insulin resistance associated with
marked increases in liver and muscle lipid content. Nat1 KO
mice also displayed reduced whole-body energy expenditure
and reduced mitochondrial activity. Taken together, these
studies demonstrate that Nat1 deletion promotes reduced mi-
tochondrial activity and is associated with ectopic lipid-induced
liver and muscle insulin resistance.
Author contributions: J.P.C., K.F.P., and G.I.S. designed research; J.P.C., Y.W., K.F., N.C.,
and K.F.P. performed research; J.P.C., Y.W., K.F., K.F.P., and G.I.S. analyzed data; and
J.P.C., K.F.P., and G.I.S. wrote the paper.
Reviewers: J.W.K., Stanford University School of Medicine; and C.S.-P., Garvan Institute of
Medical Research.
The authors declare no conflict of interest.
This open access article is distributed under Creative Commons Attribution-NonCommercial-
NoDerivatives License 4.0 (CC BY-NC-ND).
1J.P.C. and Y.W. contributed equally to this work.
2To whom correspondence should be addressed. Email: gerald.shulman@yale.edu.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1716990115/-/DCSupplemental.

















in 3T3-L1 adipocytes (13), Nat1 KO mice fed RC did not dis-
play any alteration in WAT lipolysis measured in vivo, evalu-
ated by nonesterified fatty acid (NEFA) levels (Table 1),
palmitate turnover, and glycerol turnover (Fig. 1 E and F).
Next, to determine whether Nat1 KO mice would be more
prone to HFD-induced insulin resistance, the rodents were fed a
HFD for 4 wk before the hyperinsulinemic-euglycemic clamp
was performed. Nat1 deficiency induced severe whole-body in-
sulin resistance, observed by a reduction in the glucose infusion
rate required to maintain euglycemia during the clamp (Fig. 1G)
compared with WT mice. This reduction in glucose infusion rate
was accounted for by reduced whole-body glucose turnover during
the clamp (Fig. 1H), and consequently, reduction in insulin-
stimulated muscle and WAT glucose uptake (Fig. 1I), as well as
severe hepatic insulin resistance, as reflected by the lack of sup-
pression in endogenous glucose production during the clamp (Fig.
1J) and a severe defect in insulin-stimulated suppression in WAT
lipolysis (Fig. 1 K and L).
Nat1 Deficiency Leads to Ectopic Lipid Accumulation in Liver and
Muscle and Reduced Insulin Signaling in Liver and Skeletal Muscle.
Given the strong causal relationship between ectopic lipid ac-
cumulation and hepatic and muscle insulin resistance shown in
previous studies (4, 14–16), we measured DAG and ceramide
content as well as translocation (activation) of PKCe in liver and
PKCθ in skeletal muscle in RC and HFD rodents. Hepatic TAG,
DAG, and ceramides were increased in KO mice in either the
RC or HFD condition (Fig. 2 A–C and Tables S1 and S3). Consis-
tent with increased DAG content in liver, Nat1 KO mice fed
either RC or a HFD displayed increased PKCe activation (Fig.
2D), suggesting the increased hepatic DAG content led to
hepatic insulin resistance through activation of PKCe, as previously
demonstrated (5, 17–19).
Ectopic lipid content was also evaluated in skeletal muscle.
TAG and DAG content were increased in muscle from Nat1 KO
mice fed either RC or a HFD (Fig. 2 E and F and Tables S2 and S4).
In contrast to what was observed in liver, ceramide content was
not increased in skeletal muscle from RC-fed mice, despite the
presence of muscle insulin resistance (Fig. 2G). Nat1 KO mice
fed a HFD displayed increased muscle DAG (Fig. 2F) and
ceramide content (Fig. 2G), and the increased DAG content in
muscle was associated with increased PKCθ activation (Fig. 2H).
Increased DAG content in liver and skeletal muscle has been
shown to play a causal role in liver and muscle insulin resistance
by activation of PKCe in liver and PKCθ in skeletal muscle,
leading to inhibition of insulin signaling at the level of the insulin
receptor kinase (IRK) in liver (17–19) and at the level of insulin
receptor substrate 1 tyrosine phosphorylation in skeletal muscle
(5, 6, 8, 9). Consistent with this hypothesis, increased DAG
content in liver in Nat1 KO mice was associated with reduced
insulin-stimulated IRK tyrosine phosphorylation and Akt phos-
phorylation in liver (Fig. 2 I–K), which provides further support
of recent studies demonstrating that DAG activation of PKCe in
liver promotes increased phosphorylation of a critical threonine
(threonine1160 human IRK, threonine1150 mouse IRK) in the
catalytic subunit of the IRK leading to decreased IRK tyrosine
phosphorylation and reduced IRK activity (19). Consistent with
DAG activation of PKCθ inhibiting insulin signaling downstream
of the IRK, Nat1 KO mice displayed reduced insulin-stimulated
Akt phosphorylation in skeletal muscle without any changes in
IRK tyrosine phos-phorylation (9) (Fig. 2 L–N).
Nat1 Deficiency Was Associated with Decreased Energy Expenditure
and Mitochondrial Dysfunction. Previous studies in humans have
found a strong relationship between increased ectopic lipid
content in liver and skeletal muscle and insulin resistance, and
hypothesized that reduced mitochondrial activity in these organs
may be a predisposing factor for increased ectopic lipid ac-
cumulation and insulin resistance in these organs (20–23). To
evaluate whether whole-body oxygen consumption and energy
expenditure were altered in these Nat1 KO mice, these parameters
were assessed by metabolic cages. Whole-body oxygen consump-
tion, carbon dioxide production, and energy expenditure were
reduced in Nat1 KO mice fed RC compared with WT mice (Fig.
3 A–C), without any difference between groups regarding quo-
tient respiratory, caloric intake, drinking, and activity (Fig. 3 D–G).
These effects were also observed in Nat1 KO mice fed HFD,
displaying reduced whole-body oxygen consumption, carbon di-
oxide production, and energy expenditure (Fig. 3 H–J). In con-
trast, there was no difference among groups regarding quotient
respiratory, caloric intake, drinking, and activity (Fig. 3 K–N).
We also performed an evaluation of oxygen consumption in
hepatocytes, WAT, and brown adipose tissue (BAT) isolated
from Nat1 KO and WT mice by Seahorse analyses to determine
whether these tissues were contributing to the reduced whole-
body energy expenditure in the Nat1 KO mice. In vitro oxygen
consumption in WAT and BAT were reduced in Nat1 KO mice
compared with WT mice (Fig. 4 A–C). Hepatocytes from Nat1
KO mice also displayed reduced oxygen consumption in vitro
compared with WT mice (Fig. 4 D and E).
Discussion
A single-nucleotide polymorphism in the human Nat2 gene has
recently been identified to be associated with insulin resistance
in humans. However, the mechanism by which alterations in the
Nat2 gene might cause insulin resistance is unknown. To address
this question, we performed a comprehensive metabolic analysis
of murine ortholog Nat1 KO mice fed either RC or a HFD.
Specifically, we examined basal and insulin-stimulated rates of
liver, muscle, and WAT glucose metabolism assessed by a
hyperinsulinemic-euglycemic clamp study. These measurements
were combined with assessment of whole-body energy expendi-
ture, activity, food intake, and 1H NMR measurements of lean
body and fat mass, as well as LC-MS/MS analyses of liver and
muscle lipid intermediates (ceramides, DAGs), which have been
implicated as causal factors in liver and muscle insulin resistance.
Using this approach, we find that Nat1 KO mice displayed whole-
body insulin resistance on a RC diet, with reduced insulin-stimulated
glucose uptake in skeletal muscle and reduced insulin-stimulated sup-
pression of endogenous glucose production during a hyperinsulinemic-
euglycemic clamp. Interestingly, insulin resistance in liver and
skeletal muscle was further exacerbated when the Nat1 KO mice
Table 1. General parameters from WT and Nat1 KO mice fed
either RC or a HFD at 12 wk of age
Parameters WT KO
Body weight (RC), g 27.5 ± 0.4 27.6 ± 0.5
Body fat (RC), g 1.7 ± 0.1 2.0 ± 0.2
Body weight (HFD), g 34.2 ± 1.3 36.5 ± 0.9
Body fat (HFD), g 7.9 ± 0.8 9.9 ± 0.8
Fasting insulin (RC), μU/mL 5.4 ± 0.7 6.9 ± 0.8
Clamped insulin (RC), μU/mL 34.9 ± 2.6 35.9 ± 1.8
Fasting Insulin (HFD), μU/mL 14.0 ± 3.3 37.4 ± 8.5*
Clamp insulin (HFD), μU/mL 97.3 ± 5.2 110.5 ± 10.3
Basal NEFA (RC), mmol/L 1.14 ± 0.07 1.12 ± 0.08
Clamp NEFA (RC), mmol/L 0.34 ± 0.03 0.39 ± 0.02
Basal NEFA (HFD), mmol/L 1.18 ± 0.07 1.15 ± 0.05
Clamp NEFA (HFD), mmol/L 0.70 ± 0.05 1.11 ± 0.05**
Plasma TAG (RC), mg/dL 94.5 ± 4.6 99.8 ± 5.9
Plasma TAG (HFD), mg/dL 92.3 ± 3.7 91.1 ± 5.0
Plasma FGF21 (RC), pg/mL 423.2 ± 61.9 540.1 ± 80.8
Data are represented as mean ± SEM (n = 8–10 per group).
*P < 0.05.
**P < 0.001 compared with WT mice fed the same diet.
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Fig. 1. Nat1 KO mice display insulin resistance in liver, muscle, and WAT, which was exacerbated by HFD. Time-course of plasma glucose and glucose
infusion rates (GIR) (A) during the hyperinsulinemic-euglycemic clamp of WT and Nat1 KO mice fed RC. (B) Whole-body insulin-stimulated glucose
uptake. (C ) Insulin-stimulated skeletal muscle and WAT 2-deoxy-glucose uptake. (D) Basal and clamp endogenous glucose production. (E ) Basal and
clamp palmitate turnover. (F ) Basal and clamp glycerol turnover. (G) Time-course of plasma glucose and GIR during the hyperinsulinemic-euglycemic
clamp of WT and Nat1 KO mice fed a HFD. (H) Whole-body insulin-stimulated glucose uptake. (I) Insulin-stimulated skeletal muscle and WAT 2-deoxy-glucose
uptake. (J) Basal and clamp endogenous glucose production. (K) Basal and clamp palmitate turnover. (L) Basal and clamp glycerol turnover. Data are represented
as mean ± SEM (n = 10 per group).

















Fig. 2. Nat1 KO mice display increased ectopic lipid content and reduced insulin signaling in liver and skeletal muscle. Hepatic TAG (A), hepatic membrane
DAG (B), and hepatic ceramides (C) content in WT and KO mice fed either RC or a HFD. Hepatic PKCe activation (D) in WT and KO mice fed either RC or a HFD.
Muscle TAG (E), muscle membrane DAG (F), and muscle ceramides (G) content in WT and KO mice fed either RC or a HFD. Muscle PKCθ activation (H) in WT
and KO mice fed either RC or a HFD. Western blot images and quantification for insulin-stimulated IRK phosphorylation pY1158 (I) and pY1162 (J), and Akt
phosphorylation (K) in liver. Western blot images and quantification for insulin-stimulated IRK phosphorylation pY1158 (L) and pY1162 (M) and Akt
phosphorylation (N) in muscle. Data are represented as mean ± SEM (n = 8–12 per group).
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were fed a HFD. In addition to the reduced insulin-stimulated
muscle glucose uptake and decreased suppression of hepatic
glucose production, Nat1 KO mice also displayed reduced insulin-
stimulated suppression of WAT lipolysis, which may have contrib-
uted to the severe metabolic phenotype in these mice (24).
Ectopic lipid deposition in liver and skeletal muscle has been
shown to be strongly associated with insulin resistance in liver and
muscle (9, 25, 26), and increases in DAGs (4, 6, 7, 9, 14, 27) and
ceramides (10–12) have both been implicated at the molecular
triggers in this process. Increased DAG content in liver has been
shown to promote increase PKCe translocation to the plasma mem-
brane, which in turn has been shown to phosphorylate threonine1160
(threonine1150 mouse) in the IRK catalytic domain, leading to
inhibition of IRK activity (17–19). In contrast, increases in muscle
DAG content have been shown to increase PKCθ translocation,
leading to decreased insulin signaling at the level of IRS-1 tyrosine
phosphorylation (28–30). These findings have recently been
translated to humans, in that increased DAG content and PKCe
Fig. 3. Nat1 KO mice display reduced whole-body energy expenditure. Whole-body oxygen consumption (A), carbon dioxide production (B), energy ex-
penditure (C), respiratory exchange ratio (D), caloric intake (E), drinking (F), and daily activity (G) in WT and KO mice fed RC. Whole-body oxygen con-
sumption (H), carbon dioxide production (I), energy expenditure (J), respiratory exchange ratio (K), caloric intake (L), drinking (M), and daily activity (N) in WT
and KO mice fed a HFD. Data are represented as mean ± SEM (n = 10 per group).

















translocation have been shown to be strongly associated with he-
patic insulin resistance in obese individuals undergoing bariatric
surgery (31, 32), and increased DAG content and PKCθ trans-
location were found to be strongly associated with muscle insulin
resistance in obese subjects and patients with type 2 diabetes (33).
Consistent with this mechanism, we observed an increase in liver
and muscle DAG content in Nat1 KO mice that was associated
with an increase in PKCe and PKCθ in liver and muscle, respec-
tively. In contrast, we saw only small increases in hepatic ceramide
content in Nat1 KO mice and no increase in muscle ceramide
content in Nat1 KO mice, despite the presence of muscle insulin
resistance.
To further understand the underlying mechanism responsible
for the increased ectopic lipid content in Nat1 KO mice, we
performed comprehensive metabolic cage studies for 4 consecu-
tive days to evaluate energy expenditure and feeding behavior.
We observed that the Nat1 KO mice displayed reduced whole-
body energy expenditure. Taken together, these data suggest that
decreased energy expenditure may be responsible for the in-
creased hepatic and muscle ectopic lipid accumulation and in-
sulin resistance in Nat1 KO mice. Furthermore, these results are
consistent with prior studies demonstrating that decreased en-
ergy expenditure in rodents leads to reduced insulin sensitivity
associated with increased ectopic lipid content (15), and that
increased energy expenditure resulting from increased mito-
chondrial activity in liver and/or skeletal muscle (27, 28, 34, 35)
can protect mice from HFD-induced insulin resistance in liver
and skeletal muscle.
To understand which tissues might be responsible for the re-
duced whole-body energy expenditure in Nat1 KO mice, we
assessed in vitro oxygen consumption in WAT, BAT, and pri-
mary hepatocytes obtained from Nat1 KO and age- and weight-
matched littermate WT mice. Using this approach, we found that
oxygen consumption was markedly reduced in all these tissues,
suggesting Nat1 deficiency may lead to global reductions in mi-
tochondrial activity in all tissues. Indeed, it was recently shown
that Nat1 KO mice display mitochondrial dysfunction (36),
corroborating our data. This manuscript showed that mito-
chondria from Nat1 KO mice displayed increased superoxide
production and reduction in PGC-1α expression, as well as mi-
tochondrial genes (such as Nrf1, Tfam, Cyscs, and Atp5). These
alterations resulted in reduced mitochondria oxygen consump-
tion, reduced whole-body energy expenditure, and reduced ex-
ercise tolerance. The authors in this study performed the in vivo
experiments in 16-wk-old mice, which resulted in differences in
body weight between groups. Knowing that differences in body
weight can profoundly affect the analysis of whole-body energy
metabolism (37), we extended these findings of in vivo energy
metabolism in Nat1 KO mice by performing all the experiments
in body weight-matched mice (12-wk-old mice) and examining
these same parameters in HFD-fed Nat1 KO mice. Moreover,
most of the in vitro oxygen measurement data by Chennamsetty
et al. (36) were collected from immortalized cell lines with knock-
down of Nat1 protein. Here, we expanded and corroborated these
findings by measuring oxygen consumption in WAT and BAT as
Fig. 4. Nat1 KO mice have lower tissue oxygen consumption. Oxygen consumption rates (OCR) measured in gonadal fat (A), inguinal fat (B), BAT (C), and
isolated primary hepatocytes (D and E) from WT and KO mice. Data are represented as mean ± SEM (n = 5 per group).
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well as primary hepatocytes from WT and Nat1 KO mice, showing
that all these tissues displayed reduced oxygen consumption.
Insulin resistance associated with mitochondrial dysfunction is
a notable finding, as this relationship has been described in ro-
dents (27, 38, 39), as well as in humans (20–23), where reductions
in mitochondrial oxidative-phosphorylation activity assessed by in
vivo NMR spectroscopy was found to be associated with increased
ectopic lipid content and insulin resistance in muscle of lean
healthy elderly people and insulin-resistant offspring of patients
with type 2 diabetes who are prone to develop diabetes later in life
(20–23, 40). The results complement previous studies demon-
strating a key role for alterations in mitochondrial dysfunction in
the pathogenesis of insulin resistance, which found that aging-
associated reduction in mitochondrial activity and aging-associated
ectopic lipid (DAG-novel PKC)-induced insulin resistance in
liver and skeletal muscle can be prevented by targeting catalase
to the mitochondria (27).
In summary, these data demonstrate that deletion of the
Nat1 gene in mice caused reduced mitochondrial activity, which
resulted in decreased whole-body energy expenditure and in-
creased ectopic lipid accumulation in liver and skeletal muscle.
Increased DAG content in liver and skeletal muscle was asso-
ciated with increased PKCe (liver) and PKCθ (muscle) activity
and insulin resistance in liver and skeletal muscle when mice
were fed a RC diet. These effects were further exacerbated when
Nat1 KO mice were challenged with a HFD.
These data provide insights into how variants in the Nat2
gene may predispose humans to insulin resistance and type
2 diabetes and provide a potential genetic link between mito-
chondrial dysfunction with increased ectopic lipid deposition
and insulin resistance.
Methods
Animal Procedures. Nat1 KOmice were obtained from Jackson Labs. Mice were
then generated for experiments breeding heterozygous × heterozygousmice to
obtain WT and KO littermates mice. The animals were individually housed
under controlled temperature (23 °C) and lighting (12:12 h light/dark cycle,
lights on at 7:00 AM) conditions, with free access to water and food. Mice were
fed either RC or a HFD (D12492; Research Diets) for 4 wk. Body composition was
assessed by 1H magnetic resonance spectroscopy, using a Bruker Minispec an-
alyzer (Bruker BioSpin). All experimental procedures were approved by and
conducted in accordance with the Institutional Animal Care and Use Committee
guidelines of Yale University School of Medicine.
Hyperinsulinemic-Euglycemic Clamp Studies. Hyperinsulinemic-euglycemic clamps
were performed as previously described (6). Briefly, a catheter was implanted in
the jugular vein 7 d before the experiments. After overnight fasting, conscious
mice were infused with [3-3H]-glucose (HPLC purified; Perkin-Elmer Life
Sciences) at a rate of 0.05 μCi/min for 120 min for basal glucose turnover
measurement. After the basal infusion, hyperinsulinemic-euglycemic clamps
were conducted for 140 min with a 3-min primed infusion of insulin
[6.0 mU/(kg-min)] and [3-3H]-glucose (0.24 μCi/min), followed by a con-
tinuous infusion of insulin [2.5 mU/(kg-min)] and [3-3H]-glucose (0.1 μCi/min),
and a variable infusion of 20% dextrose to maintain euglycemia (∼120 mg/dL).
After 85 min, a bolus of 2-deoxy-d-[1-14C]glucose (PerkinElmer) (10 μCi)
was injected to evaluate insulin-stimulated tissue glucose uptake. At the
end of the clamps, mice were anesthetized with a sodium pentobarbital injection
(150 mg/kg), and liver, WAT, and skeletal muscle (gastrocnemius + soleus) were
taken and snap-frozen in liquid nitrogen and stored at −80 °C for sub-
sequent analyses.
Comprehensive Animal Metabolic Monitoring System. Comprehensive animal
metabolic monitoring system (Columbus Instruments) was used to evaluate
O2 consumption, CO2 production, energy expenditure, activity, and food
consumption. Drinking was assessed by a computer system counting con-
sumed water droplets.
LipidMeasurements. Tissue TAGswere extracted using themethodof Folchet al.
(41) and measured using a DCL TAG reagent (Diagnostic Chemicals). For DAG
extraction, livers and muscles were homogenized in a buffer solution (20 mM
Tris·HCl at pH 7.4, 1 mM EDTA, 0.25 mM EGTA, 250 mM sucrose) containing a
protease inhibitor mixture (Roche), and samples were centrifuged at 100,000 ×
g for 1 h. The supernatants containing the cytosolic fraction and the pellet
containing the membrane fraction were collected. DAG and ceramide con-
centrations were measured by LC-MS/MS, as previously described (30). Total
cytosolic and membrane DAG and ceramide content are expressed as the sum
of individual species. All lipid measurements were made from tissues harvested
from 6-h fasted mice.
Oxygen Consumption Measurements. Primary hepatocytes from WT and KO
mice were isolated at the Yale Liver Center. Cells were washed three times with
recovery media (DMEMwith high glucose plus 10% FBS), and an equal amount
of cells (12,000) was seeded in each well of a Seahorse XF24 cell culture plate
(Seahorse Bioscience). These experiments were repeated six times under the
same conditions as previously described (14). Briefly, cells were kept in recovery
media for 4–6 h and then washed with DMEM media (low glucose plus 10%
FBS) and incubated overnight. The following morning, cells were washed with
prewarmed (∼37 °C) XF24 Assay media. XF24 Assay media (525 μL) was then
added to each well. Immediately before measurements, cells with assay media
were placed in an unbuffered, humidified incubator at 37 °C for 1 h to allow
temperature and pH equilibration. Three measurements of oxygen consump-
tion rate were taken, and the average of three measurements was used for
analysis. These experiments were repeated six times using six different mice per
group under the same conditions.
In addition, freshly isolated mouse gonadal or inguinal s.c. WAT or BAT
were rinsed with XF-DMEM (containing 25 mM Hepes) and cut into small
pieces (∼10 mg). After extensive washing, one piece of tissue was placed in
each well of a XF24 Islet Capture Microplate (Seahorse Bioscience) and
covered with the islet capture screen that allows free perfusion while min-
imizing tissue movement. XF Assay Medium (500 μL) was added, and samples
were analyzed in the XF24 Analyzer.
Immunoblot Analysis. Tissues were homogenized in RIPA lysis buffer sup-
plemented with protease inhibitor mixture (Roche) for protein isolation.
Proteins from homogenized liver or skeletal muscle (100 μg protein extracts)
were electrophoretically separated by 4–12% SDS/PAGE (Invitrogen) and
then transferred to polyvinylidene difluoride membranes (Millipore), using a
semidry transfer cell (Bio-Rad) for 120 min. After blockade of nonspecific
sites with 5% nonfat dry milk TBST (10 mM Tris, 100 mM NaCl, 0.1% Tween
20) solution, membranes were incubated overnight at 4 °C with the fol-
lowing primary antibodies: total IRK, tyrosine pY1158 IRK, tyrosine pY1162
IRK, total Akt, and Akt phosphorylation Ser473 (Santa Cruz Biotechnology,
Inc.), PKCe (BD Transduction Laboratories), PKCθ (BD Transduction Labora-
tories), or GAPDH (Santa Cruz Biotechnology, Inc.). After washing with TBST,
membranes were incubated with peroxidase-conjugated anti-rabbit, or anti-
mouse. Membranes were thoroughly washed, and immune complexes were
detected using an enhanced luminol chemiluminescence system (Thermo
Scientific) and subjected to photographic films. Signals on the immunoblot
were quantified by optical densitometry (Scion Image Software).
Statistics. All data are expressed as mean ± SEM. Results were assessed using
two-tailed unpaired Student’s t test or two-way ANOVA (GraphPad Prism 5).
A P value less than 0.05 was considered significant.
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